JP2022529037A5 - - Google Patents

Info

Publication number
JP2022529037A5
JP2022529037A5 JP2021561780A JP2021561780A JP2022529037A5 JP 2022529037 A5 JP2022529037 A5 JP 2022529037A5 JP 2021561780 A JP2021561780 A JP 2021561780A JP 2021561780 A JP2021561780 A JP 2021561780A JP 2022529037 A5 JP2022529037 A5 JP 2022529037A5
Authority
JP
Japan
Prior art keywords
tablet
tablet according
cannabinoids
sugar alcohol
module
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021561780A
Other languages
English (en)
Japanese (ja)
Other versions
JP7556882B2 (ja
JP2022529037A (ja
Filing date
Publication date
Priority claimed from CA3040513A external-priority patent/CA3040513C/en
Priority claimed from CA3040547A external-priority patent/CA3040547C/en
Priority claimed from CA3040532A external-priority patent/CA3040532C/en
Priority claimed from US16/386,477 external-priority patent/US10925853B2/en
Priority claimed from US16/713,580 external-priority patent/US11633351B2/en
Priority claimed from CA3065042A external-priority patent/CA3065042C/en
Application filed filed Critical
Priority claimed from PCT/DK2020/050102 external-priority patent/WO2020211915A1/en
Publication of JP2022529037A publication Critical patent/JP2022529037A/ja
Publication of JP2022529037A5 publication Critical patent/JP2022529037A5/ja
Publication of JP7556882B2 publication Critical patent/JP7556882B2/ja
Application granted granted Critical
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021561780A 2019-04-17 2020-04-17 速崩壊カンナビノイド錠剤 Active JP7556882B2 (ja)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
CA3040532 2019-04-17
CA3040513A CA3040513C (en) 2019-04-17 2019-04-17 An oral cannabinoid tablet
US16/386,477 US10925853B2 (en) 2019-04-17 2019-04-17 Oral cannabinoid tablet
CA3040532A CA3040532C (en) 2019-04-17 2019-04-17 Lozenge for improved delivery of cannabinoids
CA3040547 2019-04-17
US16/386,477 2019-04-17
CA3040547A CA3040547C (en) 2019-04-17 2019-04-17 Cannabinoid lozenge formulation
CA3040513 2019-04-17
CA3065042 2019-12-13
US16/713,580 US11633351B2 (en) 2019-12-13 2019-12-13 Fast disintegrating cannabinoid tablets
CA3065042A CA3065042C (en) 2019-12-13 2019-12-13 Fast disintegrating cannabinoid tablets
US16/713,580 2019-12-13
PCT/DK2020/050102 WO2020211915A1 (en) 2019-04-17 2020-04-17 Fast disintegrating cannabinoid tablets

Publications (3)

Publication Number Publication Date
JP2022529037A JP2022529037A (ja) 2022-06-16
JP2022529037A5 true JP2022529037A5 (cg-RX-API-DMAC10.html) 2023-04-24
JP7556882B2 JP7556882B2 (ja) 2024-09-26

Family

ID=70802555

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021561780A Active JP7556882B2 (ja) 2019-04-17 2020-04-17 速崩壊カンナビノイド錠剤

Country Status (12)

Country Link
EP (2) EP4268815A3 (cg-RX-API-DMAC10.html)
JP (1) JP7556882B2 (cg-RX-API-DMAC10.html)
CN (1) CN113784704A (cg-RX-API-DMAC10.html)
AU (1) AU2020258631B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021020523A2 (cg-RX-API-DMAC10.html)
DK (1) DK3920891T3 (cg-RX-API-DMAC10.html)
ES (1) ES2975266T3 (cg-RX-API-DMAC10.html)
FI (1) FI3920891T3 (cg-RX-API-DMAC10.html)
MX (1) MX2021012712A (cg-RX-API-DMAC10.html)
PL (1) PL3920891T3 (cg-RX-API-DMAC10.html)
WO (1) WO2020211915A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA202107389B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020412501A1 (en) * 2019-12-24 2022-08-18 Cannadol Pharmaceuticals Ltd Compositions comprising terpenes and their use in the treatment or alleviation of pain or anxiety
TWI923583B (zh) * 2020-04-14 2026-05-01 美商健生生物科技公司 包含胺基嘧啶衍生物或其醫藥上可接受之鹽之用於經口投予之醫藥組成物
LT4243797T (lt) * 2020-11-16 2026-06-10 Orcosa Inc. Greitos infuzijos platforma ir kompozicijos, skirtos žmonių terapiniam gydymui
US11672761B2 (en) * 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
CN114748429A (zh) * 2020-12-29 2022-07-15 汉义生物科技(北京)有限公司 一种水溶性大麻素制剂及其制备方法
JP2023010677A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物
JP2023010676A (ja) * 2021-07-09 2023-01-20 株式会社東洋新薬 固形組成物
US20240415853A1 (en) * 2023-03-21 2024-12-19 Fertin Pharma A/S Cannabinoid Self-Emulsifying Systems
JP2025529608A (ja) * 2023-07-24 2025-09-09 ポビバ コーポレーション てんかんを処置する為の組成物及び方法
DK202330231A1 (en) * 2023-09-27 2025-04-10 Fertin Pharma As Cannabidiol for alleviating xerostomia
CN118021744A (zh) * 2024-02-05 2024-05-14 谛邈生物科技(北京)有限公司 一种大麻二酚型大麻素化合物冻干闪释片及其制备方法
DK202430722A1 (en) * 2024-11-25 2026-06-09 Fertin Pharma As Sugar free soft chew tablets

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1361864T3 (en) * 2001-02-14 2014-03-03 Gw Pharma Ltd FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids
GB0320854D0 (en) * 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
CA2664315C (en) * 2006-09-15 2016-01-19 Echo Pharmaceuticals B.V. Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
EP2164462B1 (de) * 2007-06-06 2017-05-31 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US20090004248A1 (en) * 2007-06-29 2009-01-01 Frank Bunick Dual portion dosage lozenge form
US9023322B2 (en) * 2008-03-26 2015-05-05 Stichting Sanammad Chewing gum compositions comprising cannabinoids
WO2009151072A1 (ja) * 2008-06-13 2009-12-17 大日本住友製薬株式会社 口腔内速崩壊錠及びその製造方法
KR20130076015A (ko) * 2011-12-28 2013-07-08 주식회사 삼양바이오팜 높은 경도를 갖는 속붕정 및 이의 제조 방법
EP2609912A1 (en) * 2011-12-30 2013-07-03 Deva Holding Anonim Sirketi Pharmaceutical combination of fingolimod and nabiximols
CA2845443A1 (en) * 2014-03-04 2015-09-04 Pharmascience Inc. Orally disintegrating tablet of nabilone and method of manufacturing
CA2992923C (en) * 2014-07-21 2021-06-29 Pharmaceutical Productions, Inc. Solid dosage form composition for buccal and sublingual administration of cannabinoids
WO2016092539A1 (en) * 2014-12-07 2016-06-16 One World Cannabis Ltd Use of cannabis to treat migraine
EP3253368A4 (en) * 2015-02-02 2018-08-22 Axim Biotechnologies, Inc. Cannabinoid and sugar alcohol complex, methods to make and use
US10765658B2 (en) * 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
KR20220132674A (ko) * 2016-08-03 2022-09-30 젤리라 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
CA3052564A1 (en) * 2017-02-05 2018-08-09 CannTab Therapeutics Limited Flash-melt cannabinoid formulations
US10772837B2 (en) * 2017-03-16 2020-09-15 CannTab Therapeutics, Ltd Modified release multi-layer tablet cannabinoid formulations
JP2020520966A (ja) * 2017-05-22 2020-07-16 ジービーエス グローバル バイオファーマ,インコーポレイテッド Trpv1を標的にするミルセン及びカンナビノイド含有組成物
JP2021513566A (ja) * 2018-02-09 2021-05-27 ニュートリスキ インターナショナル インク.Neutrisci International Inc. スチルベノイドとカンナビノイドとの共結晶を含む組成物

Similar Documents

Publication Publication Date Title
FI3920891T3 (fi) Nopeasti hajoavat kannabinoiditabletit
US20210322368A1 (en) Solid dosage form composition for buccal or sublingual administration of cannabinoids
CA2752435C (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives and pharmaceutical dosage form thereof
JP2012517975A (ja) 1型糖尿病、2型糖尿病、耐糖能障害又は高血糖の治療用sglt−2阻害薬
CN120091810A (zh) 用于治疗病毒性疾病的方法和生物利用度高渗透性化合物
US20250099523A1 (en) Orally disintegrating, sublingual and buccal formulations
JP6133445B2 (ja) 口腔内速崩壊性固形製剤用組成物
CA3052564A1 (en) Flash-melt cannabinoid formulations
JP2018521985A5 (cg-RX-API-DMAC10.html)
KR20150056636A (ko) 산형(酸型) 카르복시 메틸 셀룰로오스 및 결정 셀룰로오스를 포함하는 붕해성 입자 조성물 및 그 조성물을 포함하는 구강내 붕해 정제
JP2022553653A (ja) 高親油性生理活性物質の放出制御製剤
KR20010073229A (ko) 조절 방출형 인슐린 감작제용 제약 조성물
WO2012093972A1 (en) Water soluble dosage forms
CN113365612B (zh) 用于生产包含银杏叶干提取物的易服用片剂的方法
RU2007137434A (ru) Таблетированный препарат с замедленным высвобождением для вертиго
US20060188591A1 (en) Bauhinia extracts
CN102727456B (zh) 药物口腔崩解片及其制备方法
CN101674850A (zh) 狭花天竺葵和肾叶天竺葵的干提取物
Rajput et al. ORODISPERSIBLE TABLETS AS MODERN ORAL SOLID DOSAGE FORMS
WO2020183436A1 (en) Dosage forms for oral delivery of cannabinoids, method of preparation and uses of same
JP6262490B2 (ja) 口腔内速崩壊性錠剤用組成物
JP7451124B2 (ja) 内服組成物およびその吸湿抑制方法
KR20080080318A (ko) 지용성 약물을 함유하는 구강내 속붕정
JP7814075B1 (ja) 錠剤
JP7680822B2 (ja) 糖尿病治療剤